| Literature DB >> 30349201 |
Huyen Phuc Do1,2, Bach Xuan Tran3,4, Quyen Le Pham5, Long Hoang Nguyen6,7, Tung Thanh Tran2, Carl A Latkin3, Michael P Dunne1,8, Philip Ra Baker1.
Abstract
PURPOSE: To synthesize evidence of the effects and potential effect modifiers of different electronic health (eHealth) interventions to help people quit smoking.Entities:
Keywords: computer; eHealth; effectiveness; mHealth; smoking cessation intervention; website
Year: 2018 PMID: 30349201 PMCID: PMC6188156 DOI: 10.2147/PPA.S169397
Source DB: PubMed Journal: Patient Prefer Adherence ISSN: 1177-889X Impact factor: 2.711
“Textword” searches
| Topic | Key terms |
|---|---|
| Smoking | Tobacco, smok*, cigarette |
| Device | Mobile phone, smartphone, smart-phone, computer, tablet, handheld, cellular phone, cell phone |
| eHealth | Online, mobile, technology, electronic health, eHealth, chat room, social media, mobile application, mobile health application, mhealth, text messaging, telemedicine, internet, multimedia, web, electronic mail, e-mail |
| Intervention | Intervent*, prevent*, trial, campaign |
Abbreviations: eHealth, electronic health; mHealth, mobile health.
Subgroups of effect modifiers employed in the meta-analysis and meta-regression
| Effect modifiers | Subgroup |
|---|---|
| Follow-up time- points | 1. <6 months of follow-up – short-term abstinence |
| 2. ≥6 months of follow-up – long-term abstinence | |
| Effective public health practice project ranking | 1. Weak quality (high risk of bias) |
| 2. Moderate quality (moderate risk of bias) | |
| 3. Strong quality (low risk of bias) | |
| Target population | 1. Adult smokers |
| 2. Youths | |
| 3. Other vulnerable subjects (chronic patients, pregnant women, and so on) | |
| Tailored intervention | 1. Tailored intervention |
| 2. Untailored intervention | |
| Interactive intervention | 1. Interactive |
| 2. Noninteractive | |
| Frequency of text message | 1. High frequency |
| 2. Low frequency | |
| Control characteristics | 1. Nonactive control group |
| 2. Active control group | |
| 3. Other eHealth platforms | |
| Location of trials | 1. Developed countries (USA, EU) |
| 2. Less developed countries (rest of the world) | |
| Theory-based intervention | 1. Yes |
| 2. No | |
| Clinician contact | 1. Yes |
| 2. No |
Abbreviation: eHealth, electronic health; EU, European Union.
Figure 1PRISMA diagram of searching and screening process.
Abbreviation: eHealth, electronic health; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
General characteristics of included studies (n=91)
| Characteristics | N | % |
|---|---|---|
| • 2010 to Feb 2017 | 74 | 68.52 |
| • 2000–2009 | 33 | 30.56 |
| • 1999 | 1 | 0.93 |
| • Randomized control trial | 105 | 97.22 |
| • Quasi-experiment | 2 | 1.85 |
| • Controlled before–after studies | 1 | 0.93 |
| • Web-based | 67 | 62.04 |
| • Computer-based | 13 | 12.04 |
| • mHealth (SMS, apps) | 24 | 22.22 |
| • Others (social media, chat-room, and other electronic aids) | 4 | 3.70 |
| • USA | 58 | 53.70 |
| • Europe | 41 | 37.96 |
| • Australia and New Zealand | 6 | 5.56 |
| • Asia | 3 | 2.78 |
| • Adults | 64 | 59.26 |
| • Youth (from 15 to 24 years old) | 26 | 24.07 |
| • Patients with chronic disease, pregnant women | 18 | 16.67 |
| • Single eHealth platform | 43 | 40 |
| • Multiple eHealth platforms | 32 | 30 |
| • Combined with non-eHealth platform | 23 | 21 |
| • Combined with financial incentives | 4 | 4 |
| • Transtheoretical model | 25 | 23.15 |
| • Cognitive-behavioral therapy | 16 | 14.81 |
| • Social cognitive theory | 11 | 10.19 |
| • Multitheories | 20 | 18.52 |
| • Not available | 18 | 16.67 |
| • Others | 18 | 16.67 |
| • Self-report | 74 | 68.52 |
| • Biochemically validation (CO breath test or | 34 | 31.48 |
| urine test) | ||
| • From 1 to <6 months | 32 | 29.63 |
| • From 6 to 12 months | 48 | 44.44 |
| • More than 12 months | 28 | 25.93 |
Abbreviations: CO, exhaled carbon monoxide; eHealth, electronic health; mHealth, mobile health.
Figure 2Risk of bias graph based on review authors’ judgments across all included studies.
Figure 3Forest plot of web based intervention effects by characteristics of control group.
Abbreviations: M–H, Mantel–Haenszel; NRT, nicotine replacement therapy.
Figure 4Forest plot of mHealth intervention effects by characteristics of control group.
Abbreviations: eHealth, electronic health; M–H, Mantel–Haenszel; mHealth, mobile health.
Figure 5Forest plot of computer-assisted intervention effects by characteristics of control group.
Abbreviation: M–H, Mantel–Haenszel.
Summary of findings on effects of eHealth smoking cessation interventions, based on GRADE guidelines
| Outcome, follow-up | Summary of the effect (95% CI) | Number of participants and studies | Quality of the evidence (GRADE) | Summary for intervention |
|---|---|---|---|---|
| Web-based vs nonactive control | ||||
| Cessation, >6 months | RR 1.06 (0.99–1.16) | 11,344; | ⊕⊕⊕⊖ | Probably little or no increase upon cessation |
| Little or no increase | 11 studies | Moderate | ||
| Cessation, 6 months | RR 2.03 (1.7–2.03) | 5,560; | ⊕⊕⊖⊖ | May increase cessation |
| Important increase | 7 studies | Low | ||
| Cessation, 1–6 months | RR 1.21 (1.08–1.36) | 11,078; | ⊕⊕⊕⊖ | Probably increases cessation slightly |
| Moderate increase | 5 studies | Moderate | ||
| Tailored web-based vs untailored control group | ||||
| Cessation, any follow-up | 1.09 (1.02–1.17) | 23,493; | ⊕⊕⊕⊖ | Probably little or no increase upon cessation |
| Little or no increase | 18 studies | Moderate | ||
| Web-based vs control group, both groups received NRT/counseling | ||||
| Cessation, any follow-up | 1.29 (1.17–1.43) | 3,619; | ⊕⊕⊕⊖ | Probably increases cessation slightly |
| Moderate increase | 11 studies | Moderate | ||
| Web-based vs other eHealth modes for cessation outcome | ||||
| Cessation, any follow-up | 1.03 (0.94–1.13) | 15,568; | ⊕⊕⊕⊖ | Probably little or no increase upon cessation |
| Little or no increase | 8 studies | Moderate | ||
| mHealth vs nonactive control | ||||
| Cessation, any follow-up | 1.71 (1.35–2.16) | 2,942; | ⊕⊕⊖⊖ | May increase cessation |
| Important increase | 9 studies | Low | ||
| High-frequency vs low-frequency SMS | ||||
| Cessation, any follow-up | 1.08 (1.02–1.15) | 11,376; | ⊕⊕⊖⊖ | May make little or no difference upon cessation |
| Little or no increase | 4 studies | Low | ||
| mHealth vs other eHealth modes | ||||
| Cessation, any follow-up | 1.35 (1.04–1.75) | 2,389; | ⊕⊕⊖⊖ | May increase cessation slightly |
| Moderate increase | 4 studies | Low | ||
| Tailored SMS vs nonsmoking/untailored SMS | ||||
| Cessation, any follow-up | 1.80 (1.54–2.10) | 8,147; | ⊕⊕⊖⊖ | May increase cessation |
| Important increase | 6 studies | Low | ||
| Computer-based vs usual care | ||||
| Cessation, any follow-up | 1.16 (1.06–1.26) | 1,703; | ⊕⊕⊖⊖ | May make little or no increase upon cessation |
| Little or no increase | 9 studies | Low | ||
| Computer-based vs active control | ||||
| Cessation, any follow-up | 1.31 (1.11–1.53) | 13,435; | ⊕⊕⊖⊖ | May increase cessation slightly |
| Moderate increase | 5 studies | Low | ||
Notes: Reasons for downgrading of quality:
downgraded 1 level for significant risk of bias;
downgraded 2 levels for serious risk of bias;
downgraded 1 level of inconsistency;
downgraded 1 level for imprecision. GRADE Working Group grades of evidence. ⊕⊕⊕⊕High quality: Further research is very unlikely to change our confidence in the estimate of effect. ⊕⊕⊕⊖Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. ⊕⊕⊖⊖Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Abbreviations: eHealth, electronic health; GRADE, Grading of Recommendations Assessment, Development and Evaluation; mHealth, mobile health; NRT, nicotine replacement therapy; RR, risk ratio.
Core effect modifier using meta-regression, stratified by eHealth platforms
| Covariates | Treatment effect Log RR (95% CI) | |
|---|---|---|
| EPHPP ranking (weak–moderate–strong) | −0.146 (−0.250 to −0.041) | |
| Interactive intervention (yes vs no) | 0.030 (−0.120 to 0.179) | 0.696 |
| Tailored intervention (yes vs no) | −0.087 (−0.239 to 0.064) | 0.259 |
| Theory-based intervention (yes vs no) | −0.106 (−0.266 to 0.054) | 0.196 |
| EPHPP ranking (weak–moderate–strong) | 0.074 (−0.101 to 0.248) | 0.407 |
| Interactive intervention (yes vs no) | 0.119 (−0.047 to 0.285) | 0.16 |
| Tailored intervention (yes vs no) | 0.160 (−0.095 to 0.416) | 0.219 |
| Theory-based intervention (yes vs no) | −0.244 (−0.865 to 0.376) | 0.440 |
| Clinician contact (yes vs no) | 0.086 (−0.169 to −0.341) | 0.509 |
| EPHPP ranking (weak–moderate–strong) | 0.403 (0.221 to 0.584) | |
| Interactive intervention (yes vs no) | −0.218 (−0.471 to 0.034) | 0.09 |
| Tailored intervention (yes vs no) | 0.450 (0.185 to 0.714) | |
| Frequent messages (high vs low) | −0.224 (−0.606 to −0.359) | |
| Location of trial (less developed vs developed countries) | −0.483 (−0.606 to −0.359) |
Note: The values in bold indicate P<0.05 (statistically significant value).
Abbreviations: eHealth, electronic health; EPHPP, Effective Public Health Practice Project; mHealth, mobile health; RR, risk ratio.